Key terms
About Repligen Corporation 1.0% 15-DEC-2028
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
FIGI
BBG01KH10Q78
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.